| Last Action | to Health & Welfare (S) |
|---|---|
| Title | AN ACT relating to use of experimental treatments for terminal illnesses. |
| Bill Documents |
Bill
|
| Bill Request Number | 110 |
| Sponsors | C. Embry Jr., C. McDaniel |
| Summary of Original Version | Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials. |
| Index Headings of Original Version |
Diseases - Investigational drugs, biological products, or devices, use by terminal patients Drugs and Medicines - Investigational drugs, biological products, or devices, use by terminal patients Health and Medical Services - Terminal patients, investigational drugs, biological products, or devices Nurses - Investigational drugs, bioloical products, or devices, use by terminal patients Pharmacists - Investigational drugs, biological products, or devices, use by terminal patients Physicians and Practitioners - Investigational drugs, biological products, or devices, use by terminal patients Public Health - Investigational drugs, biological products, or devices, use by terminal patients |
| 01/06/16 |
|
|---|---|
| 01/07/16 |
|
Last updated: 1/16/2019 3:08 PM (EST)